The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial
Open accessAbstract
BACKGROUND: Disease management programmes (DMPs) are costly and impose additional work load on general practitioners (GPs). Data on their effectiveness are inconclusive. We therefore conducted a cluster-randomised controlled trial to evaluate the effectiveness of the Austrian DMP for diabetes mellitus type 2 on HbA1c and quality of care for adult patients in primary care. METHODS: All GPs of Salzburg-province were invited to participate. After cluster-randomisation by district, all patients with diabetes type 2 were recruited consecutively from 7-11/2007. The DMP, consisting mainly of physician and patient education, standardised documentation and agreement on therapeutic goals, was implemented in the intervention group while the control group received usual care. We aimed to show superiority of the intervention regarding metabolic control and process quality. The primary outcome measure was a change in HbA1c after one year. Secondary outcomes were days in the hospital, blood pressure, lipids, body mass index (BMI), enrolment in patient education and regular guideline-adherent examination. Blinding was not possible. RESULTS: 92 physicians recruited 1489 patients (649 intervention, 840 control). After 401 ± 47 days, 590 intervention-patients and 754 controls had complete data. In the intention to treat analysis (ITT) of all 1489 patients, HbA1c decreased 0.41% in the intervention group and 0.28% in controls. The difference of -0.13% (95% CI -0.24; -0.02) was significant at p = 0.026. Significance was lost in mixed models adjusted for baseline value and cluster-effects (adjusted mean difference -0.03 (95% CI -0.15; 0.09, p = 0.607). Of the secondary outcome measures, BMI and cholesterol were significantly reduced in the intervention group compared to controls in ITT after adjustments (-0.53 kg/m²; 95% CI -1.03;-0.02; p = 0.014 and -0.10 mmol/l; 95% CI -0.21; -0.003; p = 0.043). Additionally, more patients received patient education (49.5% vs. 20.1%, p < 0.0001), eye- (71.0% vs. 51.2%, p < 0.0001), foot examinations (73.8% vs. 45.1%, p < 0.0001), and regular HbA1c checks (44.1% vs. 36.0%, p < 0.01) in the intervention group. CONCLUSION: The Austrian DMP implemented by statutory health insurance improves process quality and enhances weight reduction, but does not significantly improve metabolic control for patients with type 2 diabetes mellitus. Whether the small benefit seen in secondary outcome measures leads to better patient outcomes, remains unclear. TRIAL REGISTRATION: Current Controlled trials Ltd., ISRCTN27414162.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“Background The prevalence of type 2 diabetes is rising worldwide for all age groups due to population growth, ageing, urbanisation, increasing prevalence of obesity and physical inactivity [1,2].”
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“However, the United Kingdom Prospective Diabetes Study (UKPDS) demonstrated that even small differences in HbA1c may translate into benefits regarding acute and chronic diabetic complications as well as hospital admissions in the long run [30].”
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294 · cited 1×
“Background The prevalence of type 2 diabetes is rising worldwide for all age groups due to population growth, ageing, urbanisation, increasing prevalence of obesity and physical inactivity [1,2].”
Consort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510
Improving Primary Care for Patients With Chronic Illness
Bodenheimer, T. (2002) · JAMA · doi:10.1001/jama.288.14.1775 · Cited by 2,961 · cited 1×
“The chronic care model (CCM) has been developed to improve the care for patients with chronic conditions like diabetes mellitus type 2 [6].”
CONSORT statement: extension to cluster randomised trials
Campbell, M. K., Elbourne, D. R., & Altman, D. G. (2004) · BMJ · doi:10.1136/bmj.328.7441.702 · Cited by 2,557 · cited 1×
“Details of the flow of clusters, physicians and patients through the study are shown in figure 1 as suggested by the consort statement for cluster randomised trials [17].”
Improving the reporting of pragmatic trials: An extension of the CONSORT statement
Zwarenstein, M., Treweek, S., Gagnier, J. J., Altman, D. G., Tunis, S., Haynes, B., Oxman, A. D., Moher, D., & groups, F. T. C. A. P. T. I. H. (. (2008) · BMJ · doi:10.1136/bmj.a2390 · Cited by 1,813 · cited 1×
“According to the extension of the CONSORT statement for pragmatic trials, special emphasis should be put on the generalisability (external validity) of the results [27]: Our trial is characterised by a high level of internal validity.”
Design and Analysis of Cluster Randomization Trials in Health Research
DONNER, A. P., & Klar, N. S. (2000) · Cited by 1,236
Criteria for evaluating evidence on public health interventions
Rychetnik, L., Frommer, M., Hawe, P., & Shiell, A. (2002) · Journal of Epidemiology and Community Health · doi:10.1136/jech.56.2.119 · Cited by 1,042 · cited 1×
“Randomised controlled trials have been described as the best method for appraising a causal relationship between a complex intervention and clinical outcomes [12].”
Weingarten, S. R. (2002) · BMJ · doi:10.1136/bmj.325.7370.925 · Cited by 735 · cited 2×
“One showed that overall DMPs have positive pooled effect sizes regarding improvement in care [21].”
Research works printed but not linked: 3
- Berger M, Grüßer M: Behandlungs- und Schulungsprogramm fürTyp 2 Diabetiker, die nicht Insulin spritzen. Deutscher Ärzteverlag, Köln. 1997
- Weitgasser R, Aistleitner M, König C, Rakovac I, Habacher W: Diabetesschulung "Neu" für Patienten mit Typ-2-Diabetes im Land Salzburg. Diabetes, Stoffwechsel und Herz. 2009, 18: 25-27.
- Österreichische Diabetes Gesellschaft: [Diabetes mellitus--guidelines for general practice. Revised and expanded 2007 edition]. Wien Klin Wochenschr. 2007, 119: 5-64.
Cited by
Sorted by citations
Items 101–141 of 141
Health at a Glance: Europe 2012 (Summary in Spanish)
OECD (2012) · Health at a glance. Europe · doi:10.1787/kubsiy-es
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-70-fr
Dépenses de santé à la charge des patients
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-54-fr
(2012) · Health at a glance. Europe · doi:10.1787/9789264183896-57-en
Gynécologues et obstétriciens, et sages-femmes
(2011) · Panorama de la santé · doi:10.1787/health_glance-2011-24-fr
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-30-fr
(2011) · Panorama de la santé · doi:10.1787/health_glance-2011-37-fr
(2013) · Public Health Forum · doi:10.1016/j.phf.2012.12.004
Bénéficiaires de soins de longue durée
(2011) · Panorama de la santé · doi:10.1787/health_glance-2011-69-fr
OECD (2012) · Health at a glance. Europe · doi:10.1787/9789264183896-15-en
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-31-fr
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-9-fr
OECD (2012) · Health at a glance. Europe · doi:10.1787/9789264183896-56-en
Durée moyenne de séjour à l'hôpital
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-33-fr
Physical activity among children
(2012) · Health at a glance. Europe · doi:10.1787/9789264183896-23-en
Procedural or postoperative complications
OECD (2012) · Health at a glance. Europe · doi:10.1787/9789264183896-44-en
Vaccination antigrippale des personnes âgées
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-51-fr
Avoidable admissions: Uncontrolled diabetes
OECD (2012) · Health at a glance. Europe · doi:10.1787/9789264183896-41-en
OECD (2012) · Health at a glance. Europe · doi:10.1787/9789264183896-18-en
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-7-fr
Survie et mortalité du cancer colorectal
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-49-fr
Commerce international des services de santé (tourisme médical)
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-65-fr
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-26-fr
(2011) · Panorama de la santé · doi:10.1787/health_glance-2011-10-fr
Prévalence et coût économique de la démence
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-68-fr
Admission évitable à l'hôpital : diabète non contrôlé
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-41-fr
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-72-fr
Emploi dans le secteur des soins de longue durée
OECD (2011) · Panorama de la santé · doi:10.1787/health_glance-2011-71-fr
Der Nutzen von Augenhintergrund-Screening bei Patienten mit Diabetes mellitus Typ 2
Koneczny, N., & Sönnichsen, A. C. (2018) · Zeitschrift für Allgemeinmedizin · doi:10.1007/bf03652721
Self-citationGhardashi, F., Akbarzadeh, R., Zardosht, R., & Hesari, M. H. (2023) · Journal of Research and Health · doi:10.32598/jrh.13.6.2219
Haslwanter, V., Rochau, U., Hallsson, L. R., Siebert, U., Schönherr, H., Lechleitner, M., & Oberaigner, W. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.01.011
Goh, L. H., Siah, C. J. R., Tam, W. W. S., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600528
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600534
Goh, L. H., Siah, C. J. R., Tam, W. W. S., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600537
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600522
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600519
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600525
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600543
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600540
Goh, L. H., Siah, C. J. R., Tam, W., Tai, E. S., & Young, D. Y. L. (2023) · Figshare · doi:10.6084/m9.figshare.22600531
Cheng, X., & Shi, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1860805
Metadata
- Authors
- Sönnichsen, A. C., Winkler, H., Flamm, M., Panisch, S., Kowatsch, P., Klima, G., Fürthauer, B., & Weitgasser, R.
- Affiliations
- Paracelsus Medical University (AT)
- Private Pädagogische Hochschule Augustinum (AT)
- Corresponding author
- Sönnichsen, Andreas C
- Venue
- BMC Family Practice
- Published
- 2010-11-05
- Volume
- 11
- Issue
- 1
- Pages
- 86-86
- ISSN
- 1471-2296 (ISSN-L)
- PMC
- PMC2989935
- OpenAlex
- W2057504267
- Cited by
- 141
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 13 · 2022: 4 · 2021: 2 · 2020: 5 · 2019: 1 · 2018: 6 · 2017: 2 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 41
- FWCI
- 22.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Family Practice (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Universität Heidelberg
- Paracelsus Medizinische Privatuniversität
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Family Practice › Primary Care and Health Outcomes
- Keywords
- type 2 diabetes, disease management programs, primary care, HbA1c, glycemic control, quality of care, patient education, physician training, treatment goals, body mass index, cholesterol, hospitalization, guideline adherence, cost-effectiveness, general practitioners, diabetes self-management education
- MeSH terms
- Adult, Austria, Diabetes Mellitus, Type 2, Female, Health Plan Implementation, Glycated Hemoglobin, Humans, Male, Program Development, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
